MyndBlue
MyndBlue is a digital MedTech company dedicated to developing personalized and predictive clinical scores using physiological measurements and artificial intelligence. Their mission is to help physicians detect and predict mental health troubles such as Major Depression Disorder (MDD) and Post Traumatic Stress Disorder (PTSD) in real time for earlier intervention, aiming to improve treatment success and patient quality of life. The company is driven by a multidisciplinary team of psychiatrists, psychologists, pharmacists, mathematicians, and engineers who focus on creating transparent, accurate prediction algorithms that support decision-making in messy real-world data conditions. They are at the forefront of building precision medicine in mental health through predictive AI, aiming to anticipate relapses and support better clinical outcomes.
Industries
Nr. of Employees
small (1-50)
MyndBlue
Cambridge, Massachusetts, United States, North America
Products
Personalized predictive clinical score for MDD and PTSD
A predictive scoring system that combines outpatient physiological measurements with machine learning models to estimate individual patient risk of relapse and disease-status changes.
MYNDBLUE Continuous Monitoring Platform
An AI-powered, objective, medical-grade continuous depression severity monitoring platform designed to anticipate and validate daily mental health changes and support clinical decision-making.
Personalized predictive clinical score for MDD and PTSD
A predictive scoring system that combines outpatient physiological measurements with machine learning models to estimate individual patient risk of relapse and disease-status changes.
MYNDBLUE Continuous Monitoring Platform
An AI-powered, objective, medical-grade continuous depression severity monitoring platform designed to anticipate and validate daily mental health changes and support clinical decision-making.
Services
Provision of a monitoring and notification service that analyzes outpatient physiological measurements to generate risk scores and alert clinicians in real time for earlier intervention.
Provision of a monitoring and notification service that analyzes outpatient physiological measurements to generate risk scores and alert clinicians in real time for earlier intervention.
Expertise Areas
- Predictive analytics for mental health
- Biosignature discovery from physiological data
- Physiological signal processing for ambulatory patients
- Interpretable machine learning in clinical settings
Key Technologies
- Machine learning for predictive analytics
- Physiological signal processing
- Biosignature discovery
- Neural ordinary differential equations (NODEs)
News & Updates
MyndBlue gave a talk about their latest results on distinguishing PTSD and non-PTSD in military populations at the MHSRS in Orlando, August 26-29, 2024.
On April 25, 2023, MyndBlue announced the publication of a predictive biosignature in MDD derived from physiological measurements of outpatients using machine learning, published in Scientific Reports.
An article about NODEs published on Springer.
A white paper discussing AI applications in PTSD.
Research article in Scientific Reports about MDD.
Research article in Scientific Reports about PTSD.
MyndBlue gave a talk about their latest results on distinguishing PTSD and non-PTSD in military populations at the MHSRS in Orlando, August 26-29, 2024.
On April 25, 2023, MyndBlue announced the publication of a predictive biosignature in MDD derived from physiological measurements of outpatients using machine learning, published in Scientific Reports.
An article about NODEs published on Springer.
A white paper discussing AI applications in PTSD.
Research article in Scientific Reports about MDD.
Research article in Scientific Reports about PTSD.